Drugs / TXT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06459921 Comparator | Dec 2024 → Jul 2026 overdue | gastric cancer | Xijing Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TXT | “intravenous OXA 85 mg/m² intravenous TXT 50 mg/m²” NCT06459921 ↗ |
| Route | Intravenous | “intravenous TXT 50 mg/m²” NCT06459921 ↗ |